Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1.

Orphanet journal of rare diseases·2022
Same author

Mitochondrial neurogastrointestinal encephalomyopathy: Clinical and biochemical impact of allogeneic stem cell transplantation in a Greek patient with one novel <i>TYMP</i> mutation.

Molecular genetics and metabolism reports·2021
Same author

Highlighting intrafamilial clinical heterogeneity in late-onset Pompe disease.

Molecular genetics and metabolism reports·2016
Same author

Neuroradiological, neurophysiological and molecular findings in infantile Krabbe disease: two case reports.

Balkan journal of medical genetics : BJMG·2016
Same author

Childhood Pompe disease: clinical spectrum and genotype in 31 patients.

Orphanet journal of rare diseases·2016
Same author

Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder.

Psychiatrike = Psychiatriki·2016

Related Experiment Video

Updated: Jun 24, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

Plasmalogen levels in full-term neonates.

I Labadaridis1, M Moraitou, M Theodoraki

  • 1NICU, General Hospital Nikea, Piraeus, Athens, Greece.

Acta Paediatrica (Oslo, Norway : 1992)
|March 18, 2009
PubMed
Summary

Neonates have significantly lower red blood cell plasmalogen levels compared to older children. This finding suggests a need for distinct normal values for diagnosing peroxisomal disorders in newborns, who may be more susceptible to oxidative stress.

More Related Videos

Isolation and Characterization of Human Umbilical Cord-derived Mesenchymal Stem Cells from Preterm and Term Infants
07:26

Isolation and Characterization of Human Umbilical Cord-derived Mesenchymal Stem Cells from Preterm and Term Infants

Published on: January 26, 2019

Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
08:08

Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model

Published on: June 18, 2013

Related Experiment Videos

Last Updated: Jun 24, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

Isolation and Characterization of Human Umbilical Cord-derived Mesenchymal Stem Cells from Preterm and Term Infants
07:26

Isolation and Characterization of Human Umbilical Cord-derived Mesenchymal Stem Cells from Preterm and Term Infants

Published on: January 26, 2019

Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
08:08

Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model

Published on: June 18, 2013

Area of Science:

  • Biochemistry
  • Cell Biology
  • Neonatal Medicine

Background:

  • Plasmalogens are vital phospholipids with a unique vinyl ether bond, abundant in the nervous system and muscles.
  • They play key roles in protecting against oxidative stress, myelin formation, and signal transduction.
  • Red blood cell (RBC) plasmalogen levels are crucial biomarkers for diagnosing peroxisomal disorders.

Purpose of the Study:

  • To investigate and establish normal ranges for RBC plasmalogen levels in neonates.
  • To compare neonatal plasmalogen levels with those of older children.
  • To inform diagnostic criteria for peroxisomal diseases in newborns.

Main Methods:

  • Studied 25 healthy, full-term neonates within their first five days of life.
  • Quantified RBC plasmalogens using gas chromatography.
  • Compared findings with 15 healthy children aged 1-8 years.

Main Results:

  • Neonates exhibited statistically significant lower plasmalogen levels compared to the control group of older children.
  • This indicates a developmental difference in plasmalogen concentration from birth.

Conclusions:

  • Established lower normal plasmalogen levels for neonates are necessary for accurate peroxisomal disease diagnosis.
  • Lower neonatal plasmalogen levels may increase vulnerability to oxidative stress.
  • Further research into plasmalogen function and metabolism in neonates is warranted.